VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ERIC 2022 | The importance of genomic testing in the diagnosis of CLL

Michel van Gelder, MD, PhD, Maastricht University, Maastricht, Netherlands, discusses the importance of genomic testing as a diagnostic tool for chronic lymphocytic leukemia (CLL), including identifying IGHV mutations and TP53 abnormalities, as this provides key information about life expectancy and which therapeutic route to take. This interview took place at the 2022 European Research Initiative on CLL (ERIC) Meeting.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter